Alphaeon to Acquire Eye-Surgery Laser Developer Lensar for $59M
Seeking to expand its ophthalmology products business, Alphaeon Corp. will acquire femtosecond laser developer Lensar Inc. for up to $59 million by the end of the year.
Founded in 2004 and based in Orlando, Fla., Lensar makes laser systems used in cataract treatment that enable automation of several critical surgical procedure planning and delivering elements.
"Lensar has advanced the self-pay category of precision refractive surgery both for ophthalmologists as well as their patients," said Robert E. Grant, CEO of Alphaeon. "The addition of Lensar to our lifestyle product portfolio will provide ophthalmologists with another alternative to expand their offering to patients."
Alphaeon is a social commerce company focused on self-pay health care products and services to promote consumer wellness, beauty and performance.
For more information, visit
www.lensar.com and
www.alphaeon.com.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024